期刊文献+

抗肿瘤新靶点——极光激酶及其小分子抑制剂研究进展 被引量:2

Novel anti-tumor targets: aurora kinases and their small molecule inhibitors
下载PDF
导出
摘要 极光激酶家族是一类结构与功能高度保守的丝氨酸/苏氨酸激酶,参与细胞有丝分裂中中心体成熟分离、纺锤体组装、染色体分离及胞质分裂等多个过程。极光激酶表达或功能异常都会导致遗传物质分配紊乱,继而影响基因组的稳定性。近年来,相关研究已证实极光激酶在多种肿瘤细胞中高表达并参与肿瘤的形成。目前已发现了一系列具有抑癌作用的小分子极光激酶抑制剂,有些已经进入临床试验阶段。本文主要对哺乳动物的3种极光激酶及其小分子抑制剂的研究进展进行综述。 Aurora kinases are a family of serine/threoning kinases whose structures and functions are highly conserved in different model organisms.They play significant roles in many events during cell mitosis,such as centrosome maturation and separation,spindle assembly and maintenance,chromosome segregation,cytokinesis.Overexpression of aurora kinases has been observed in some tumor cells and aberrations in aurora kinases have been proved to be strongly associated with tumorigenesis.Up to now,some small molecule aurora kinase inhibitors with anti-tumor activity have been developed.Some of those with promising pre-clinical results have reached clinical trial.This review describes the recent progress of aurora kinases and their small molecule inhibitors.
出处 《国际药学研究杂志》 CAS CSCD 2013年第1期73-78,104,共7页 Journal of International Pharmaceutical Research
关键词 极光激酶 抗肿瘤药 有丝分裂 抑制剂 aurora kinases antineoplastic agents mitosis inhibitors
  • 相关文献

参考文献36

  • 1Tseng TC,Chen SH,Hsu YP. Protein kinase profile of sperm and eggs:cloning and characterization of two novel testisspecific protein kinases (AIE1,AEI2) related to yeast and fly chromosome segregation regulators[J].Dna and Cell Biology,1998,(10):823-833.
  • 2Katayama H,Sasai K,Kawai H. Phosphorylation by Aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53[J].Nature Genetics,2004,(01):55-62.doi:10.1038/ng1279.
  • 3Liu Q,Kaneko S,Yang L. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215[J].Journal of Biological Chemistry,2004,(50):52175-52182.
  • 4Zhou H,Kuang J,Zhong L. Tumor amplified kinase STK15/BTAK induces centrosome amplification,aneuploidy and transformation[J].Nature Genetics,1998,(02):189-193.
  • 5Furukawa T,Kanai N,Shiwaku HO. Aurora is one of the downstream targets of MQPK1/ERK2 in pancreatic cancer[J].Oncogene,2006,(35):4831-4839.
  • 6Kimura M,Matsuda Y,Yoshioka T. Identification and characterization of STK12/Aik2:a human gene related to aurora of Drosophila and yeast IPL1[J].Cytogenetics and Cell Genetics,1998,(3/4):147-152.
  • 7Bernard M,Sanseau P,Henry C. Cloning of STK13,a third human protein kinase related to Drosophila aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter[J].Genomics,1998,(03):406-409.
  • 8Hauf S,Cole RW,LaTerra S. The small molecule Hesperadin reveals a role for aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint[J].Journal of Cell Biology,2003,(02):281-294.
  • 9Murata-Hori M,Tatsuka M,Wang YL. Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis[J].Molecular Biology of the Cell,2002,(04):1099-1108.
  • 10Pahl HL. Activators and target genes of Rel/nf-kappaB transcription of factors[J].Oncogene,1999,(49):6853-6866.

二级参考文献90

  • 1Stanford J S, Lieberman S L, Wong V L, et al. Regulation of the G2/M transition in oocytes of Xenopus tropicalis. Dev Biol, 2003, 260(2): 438-448.
  • 2Mendez R, Hake L E, Andresson T, et al. Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature, 2000, 404(6775): 302-307.
  • 3Palmer A, Gavin A C, Nebreda A R. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation:p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. EMBO J, 1998, 17(17): 5037-5047.
  • 4Littlepage L E, Wu H, Andresson T, et al. Identification of phosphorylated residues that affect the activity of the mitotic kinase aurora-A. Proc Natl Acad Sci USA, 2002, 99(24):15440-15445.
  • 5Katayama H, Zhou H, Li Q, et al. Interaction and feedback regulation between STK15/BTAK/aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. J Biol Chem, 2001, 276(49): 46219-46224.
  • 6Chen S S, Chang P C, Cheng Y W, et al. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO J, 2002, 21(17): 4491-4499.
  • 7Kiat L S,Hui K M, Gopalan G. Aurora-A kinase interacting protein (AIP), a novel negative regulator of human aurora-A kinase. J Biol Chem. 2002, 277(47): 45558-45565.
  • 8Littlepage L E, Ruderman J V. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase aurora-A during mitotic exit. Genes Dev, 2002, 16(17): 2274-2285.
  • 9Bischoff J R, Plowman G D. The Aurora/Ip11p kinase family:regulators of chromosome segregation and cytokinesis.Trends Cell Biol, 1999, 9(11): 454-459.
  • 10Murata-Hori M, Tatsuka M, Wang Y L. Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell, 2002,13(4): 1099-1108.

共引文献8

同被引文献22

  • 1李强,吴燕华,闫晓梅,余龙,赵寿元.极光(aurora)激酶在细胞有丝分裂和肿瘤形成中的重要功能[J].生命科学,2005,17(5):424-432. 被引量:9
  • 2Breccia M, Lo Coco F. Thrombo-iiemorrhagic deatiis in acutepromyelocytic leukem ia[J] . Thmmb R e s,2 0 1 4 , 133( Suppl 2 ) :S112-S116.
  • 3Li J , Zhou H , Hu J , et al. Progress in the treatm ent ofacute promyelocytic leukem ia : optimization and obstruction[J] . I n t J H em atol,2 0 1 4 , 1 0 0 (1 ) :38-50.
  • 4Andrews PD , Knatlo E , Moore W J, et al. Mitotic m echanics:the auroras come into view [J] . C u rrO p in C e llBiol, 2 0 03, 1 5 (6 ) :6 7 2 I 8 3 .
  • 5Sen S , Zhou H , White RA. A putative serine/threoninekinase encoding gene BTAK on chromosome 20q13 is am plifiedand o v e rex p res/d in human bm ast c a n c r cell lines[J] . Oncogene, 1997, 1 4 (1 8 ) :2195-2200.
  • 6Bolanos-Garcia VM. Aurora kinases [J] . Int J BiochemCell Biol, 20 0 5 , 3 7 ( 8 ) : 1572-1577.
  • 7Goldenson B , Crispino JD. The auroral kinases in cell cycleand leukem ia[J] . Oncogene, 2 0 1 5,3 4 ( 5 ) :537-545.
  • 8Lens SM , Voest E E , M ed em aR H . Shared and separatefunctions of polo-like kinases and aurom kinases in cancer[J] . Nat Rev Cancer, 20 1 0 , 1 0 (1 2 ) : 825-841.
  • 9C arjindi P , Ceruti R , Giorgini ML, et al. P H A -739358,a potent inhibitor of Aurora kinases with a selective targetinhibition profilerelevant to cancer[J] . Mol Cancer Ther,2 0 0 7 , 6 ( 1 2 ) :3158-3168.
  • 10Li JP , Yang Y X ,Liu Q L,et al. The pan-inhibitor of Aurorakinases danusertib induces apoptosis and a u to p h a gand suppresses epithe/al-to-m esenchym al transition in humanbm ast cancer cells [J] . Drug Des Devel T h er,2 0 1 5,9 : 1027-1062.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部